Signal Transduction and Targeted Therapy
Open Access
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Key Metrics
View Chart Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
- PublisherSPRINGERNATURE
- LanguageEnglish
- FrequencyContinuous publication
- Article Processing ChargesEUR 2690 | USD 3190 | GBP 2390
- Publication Time5
- Editorial Review ProcessAnonymous peer review
- LanguageEnglish
- Society/Institute/SponsorSichuan University
- FrequencyContinuous publication
- Publication Start Year2016
- Publisher URL
- Website URL
- Other charges
- Plagiarism
- Publication Time5
- Waiver Policy
- Editorial Team
- Review ProcessAnonymous peer review
- Review Url
- Author instructions
- Copyright Details
- License typeCC BY
- OA statement
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Meets Top Publisher Standards: Essential for leading journals like Elsevier.Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
3000+ graphical abstracts produced with 4.8/5 customer rating | Months | % Papers published |
|---|---|
| 0-3 | 1% |
| 4-6 | 31% |
| 7-9 | 47% |
| >9 | 22% |
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Signal Transduction and Targeted Therapy been publishing? 
The Signal Transduction and Targeted Therapy has been publishing since 2016 till date.
How frequently is the Signal Transduction and Targeted Therapy published?
Signal Transduction and Targeted Therapy is published Continuous publication.
Who is the publisher of Signal Transduction and Targeted Therapy?
The publisher of Signal Transduction and Targeted Therapy is SPRINGERNATURE.
How can I view the journal metrics of Signal Transduction and Targeted Therapy on editage?
For the Signal Transduction and Targeted Therapy metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Signal Transduction and Targeted Therapy?
The eISSN number is 2059-3635 and pISSN number is 2095-9907 for Signal Transduction and Targeted Therapy.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Hepatocellular carcinoma, Virus, Mitochondrial biogenesis, Tumor microenvironment, Lung cancer, Reactive oxygen species, Neuroendocrine tumors, Gallbladder, Disease severity, Autophagy, Tyrosine hydroxylase, Immunotherapy, Central nervous system, Peroxisome, K562 cells, Tumor growth, Interferon, Colorectal cancer, Clinical trial, Dependent manner.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.